Biomedical builds on 55 years of diagnostic care
FROM a single laboratory on Caledonia Avenue to a nationwide network of more than 50 collection centres, Caledonia Medical Laboratory Limited, popularly known as Biomedical, has spent more than five decades building a reputation for accessible, accurate, and quality diagnostic services across Jamaica.
More than 55 years after four medical professionals came together to address a gap in after-hours access to laboratory results, the company continues to evolve as one of the island’s leading providers of medical laboratory services.
Founded in 1968 by medical technologist Felicity Lightbourne, cardiologist Dr Donald Christian, general practitioner Dr Ernest Wells, and pharmacist Dr Lester Woolery, the laboratory was established on the premise that physicians should be able to access reliable laboratory results for their patients even after other laboratories had closed for the day.
“Back then, physicians often had difficulty obtaining laboratory results after normal business hours. The founders therefore envisioned a laboratory that would provide timely, reliable diagnostic testing and greater accessibility for doctors and patients,” Chief Executive Officer Helen Christian said while noting that Lightbourne, as the laboratory’s founding managing director, played a pivotal role in establishing its culture of quality and technical excellence.
The company, which opened its first laboratory on Caledonia Avenue in St Andrew, spent its early years building and scaling its operations while navigating the challenges of financing laboratory equipment, maintaining quality standards with limited resources, and keeping pace with advances in laboratory science.
Christian said these challenges were, however, countered through continuous investment in staff training, quality systems, and modern laboratory technology, which allowed Biomedical to steadily expand beyond its flagship St Andrew centre.
Today, the privately owned company remains one of Jamaica’s oldest independent medical labs. It operates a largely automated central laboratory supported by more than 50 collection centres across the island. The company recently commissioned its 52nd centre and third St Ann location at Knutsford Business Centre in Drax Hall.
The opening of that location comes as the country continues to contend with chronic noncommunicable diseases, including diabetes, hypertension, cardiovascular disease and certain cancers — conditions that often develop before symptoms become apparent, making regular screening and early detection critical to improving health outcomes.
“Biomedical is a full-service laboratory, having the largest network in the local industry. Our qualified and competent staff complement includes certified technical and administrative personnel,” Christian said.
The laboratory, having expanded beyond traditional testing facilities in recent years, now offers mobile phlebotomy and house-call specimen collection services. Its portfolio includes routine and specialised blood testing, microbiology, haematology, histology, clinical chemistry, DNA and paternity testing, as well as drug and toxicology screening
“The laboratory continues to introduce new diagnostic tests, expand specialised testing capabilities, invest in modern laboratory technology, and improve digital access to patient results. Its stated vision is ‘Dominance beyond borders — delivering accurate same-day results with world-class experience’,” Christian said.
Biomedical’s operations are currently supported by registered medical technologists, a scientific officer, technical assistants, consulting clinical specialists, certified phlebotomists, and a quality management consultant, along with laboratory assistants, administrative personnel, drivers and bearers.
Among the company’s early employees was Barbara Hendriks, who later became managing director and played a significant role in its growth. In addition to Christian, the laboratory’s executive team includes Chief Operations Officer Andre Williamson, Chief Financial Officer Bridgette Campbell, and Laboratory Director Vinell Bonner-Richards.
The wider management team also includes Deputy Laboratory Director Nevin Baker, Quality Manager Natangia Parke Dryden, Business Development Manager Andrewlyn Gooden, IT Manager Richard Bernard, Administrative Manager June Bryan, Human Resource Manager Grace Ann Howell Blake, and Facilities Manager Ricardo Plummer.
Priding quality and professional standards as central to its development Biomedical has, over the years, maintained its accreditation through repeated surveillance assessments and reassessments. In May 2013 the entity became Jamaica’s first private medical laboratory to receive ISO accreditation through the Jamaica National Agency for Accreditation (JANAAC). It later transitioned to the ISO 15189:2022 standard in 2025.
Maintaining international accreditation continuously for more than a decade is among the achievements of which the company says it is most proud, alongside ensuring that its medical technologists and phlebotomists remain trained and certified.
Following the celebration of its 55th anniversary in 2023, Biomedical has continued to expand its role within the public health-care system by providing laboratory services to government-operated hospitals and supporting national health initiatives.
With sights set on further growth the company is also now seeking to expand its local footprint while exploring opportunities within the Jamaican Diaspora and wider regional markets.
Looking beyond its first 55 years and positing itself around the three main pillars of quality, innovation, and accessibility, it remains anchored by its aforementioned vision of ‘Dominance beyond borders while delivering accurate same-day results with world-class experience’. This effort is largely carried by the company’s mission aimed at communicating timely and accurate results to patients.
“The future growth of the laboratory looks very promising. The organisation’s continued emphasis on quality, innovation, and accessibility positions it well for sustained growth in the diagnostic health-care sector,” Christian also said while citing further investment in advanced diagnostic technology, alongside the continued maintenance of international accreditation standards, as critical drivers of the plans for expansion.
“We are also seeking to support Jamaica’s development as a regional health-care and medical tourism destination,” she added.